A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer - ENDO-3: ANZGOG trial 1911/2020.
Andreas ObermairJim NicklinVal GebskiSandra Christine HayesNicholas GravesLinda MileshkinMing Yin LinPhillip BealeEva BaxterKristy P RobledoCarlos Salomon GalloGeorge B HannaMonika JandaPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
NCT04073706.
Keyphrases
- phase iii
- endometrial cancer
- early stage
- double blind
- lymph node
- open label
- clinical trial
- phase ii
- placebo controlled
- sentinel lymph node
- ultrasound guided
- robot assisted
- study protocol
- randomized controlled trial
- diffusion weighted imaging
- fine needle aspiration
- radiation therapy
- squamous cell carcinoma
- computed tomography
- rectal cancer